These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19364932)

  • 1. Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.
    Oh U; Blevins G; Griffith C; Richert N; Maric D; Lee CR; McFarland H; Jacobson S
    Arch Neurol; 2009 Apr; 66(4):471-9. PubMed ID: 19364932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.
    Bielekova B; Howard T; Packer AN; Richert N; Blevins G; Ohayon J; Waldmann TA; McFarland HF; Martin R
    Arch Neurol; 2009 Apr; 66(4):483-9. PubMed ID: 19364933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo maintenance of human regulatory T cells during CD25 blockade.
    Huss DJ; Mehta DS; Sharma A; You X; Riester KA; Sheridan JP; Amaravadi LS; Elkins JS; Fontenot JD
    J Immunol; 2015 Jan; 194(1):84-92. PubMed ID: 25416807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells.
    Rech AJ; Vonderheide RH
    Ann N Y Acad Sci; 2009 Sep; 1174():99-106. PubMed ID: 19769742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.
    Jacobs JF; Punt CJ; Lesterhuis WJ; Sutmuller RP; Brouwer HM; Scharenborg NM; Klasen IS; Hilbrands LB; Figdor CG; de Vries IJ; Adema GJ
    Clin Cancer Res; 2010 Oct; 16(20):5067-78. PubMed ID: 20736326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.
    Zhang Y; McClellan M; Efros L; Shi D; Bielekova B; Tang MT; Vexler V; Sheridan JP
    Mult Scler; 2014 Feb; 20(2):156-64. PubMed ID: 23846354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.
    Vignali D; Gürth CM; Pellegrini S; Sordi V; Sizzano F; Piemonti L; Monti P
    Transplantation; 2016 Sep; 100(9):1853-61. PubMed ID: 27306531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo depletion of CD4+CD25+ regulatory T cells in cats.
    Smithberg SR; Fogle JE; Mexas AM; Reckling SK; Lankford SM; Tompkins MB; Dean GA
    J Immunol Methods; 2008 Jan; 329(1-2):81-91. PubMed ID: 17980384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients.
    Kreijveld E; Koenen HJ; Klasen IS; Hilbrands LB; Joosten I
    Am J Transplant; 2007 Jan; 7(1):249-55. PubMed ID: 17109733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.
    Bloom DD; Chang Z; Fechner JH; Dar W; Polster SP; Pascual J; Turka LA; Knechtle SJ
    Am J Transplant; 2008 Apr; 8(4):793-802. PubMed ID: 18261176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.
    Martin R
    Neurodegener Dis; 2008; 5(1):23-6. PubMed ID: 18075271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.
    Powell DJ; Attia P; Ghetie V; Schindler J; Vitetta ES; Rosenberg SA
    J Immunother; 2008; 31(2):189-98. PubMed ID: 18481388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients.
    Fritzsching B; Haas J; König F; Kunz P; Fritzsching E; Pöschl J; Krammer PH; Brück W; Suri-Payer E; Wildemann B
    PLoS One; 2011 Mar; 6(3):e17988. PubMed ID: 21437244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of cyclosporine on human regulatory T cells in vitro.
    Miroux C; Moralès O; Carpentier A; Dharancy S; Conti F; Boleslowski E; Podevin P; Auriault C; Pancré V; Delhem N
    Transplant Proc; 2009 Oct; 41(8):3371-4. PubMed ID: 19857752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
    Locke FL; Pidala J; Storer B; Martin PJ; Pulsipher MA; Chauncey TR; Jacobsen N; Kröger N; Walker I; Light S; Shaw BE; Beato F; Laport GG; Nademanee A; Keating A; Socie G; Anasetti C
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):405-411. PubMed ID: 28007665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on anti-CD25: daclizumab in MS.
    Schippling DS; Martin R
    Int MS J; 2008 Sep; 15(3):94-8. PubMed ID: 18808743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
    Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
    J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.
    Singh M; Basu S; Camell C; Couturier J; Nudelman RJ; Medina MA; Rodgers JR; Lewis DE
    Eur J Immunol; 2008 Jun; 38(6):1522-32. PubMed ID: 18446791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.